Since 1983, eight new AEDs have been introduced (see Table 2 below). Sadly, a recent VA study of more than 21,000 subjects aged 65 years and older revealed that 80% were being treated with ...

Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...

Researchers assessed whether semaglutide initiation was associated with risk for adult-onset epilepsy or seizures in adults ...

New-onset adult seizures may be due to stroke, high blood sugar, alcohol use or withdrawal, and several other medical conditions. If you had a first-time seizure as an adult, it may be a sign of ...

Motpoly XR is bioequivalent to Vimpat (lacosamide) film-coated tablets and provides a new once-daily option at equivalent doses. Motpoly XR™ (lacosamide) extended-release capsules are now available ...

Briviact (brivaracetam) is a brand-name drug prescribed to treat partial (focal onset) seizures in adults and children. Briviact comes in several dosage forms and is typically taken twice per day.

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures The CORE-VNS 36-month data analysis reaffirms the effectiveness of VNS Therapy ...

Keppra (levetiracetam) is a brand-name drug that’s prescribed for certain types of seizures in adults and some children. Keppra comes as an oral tablet and oral solution that’s typically taken twice ...

Moving forward The CDC reports that one in 100 U.S. adults has active epilepsy, and studies suggest that one third of these are not receiving adequate treatment or care. 30 Although this recent report ...

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures “It is critically important to conduct long-term, real-world studies like CORE ...